Interleukin-10 in acute respiratory virus infection
Interleukin-10 in acute respiratory virus infection
批准号:
7746088
负责人:
Thomas J Braciale
金额:
$24.83万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-06-18 至 2014-05-31
关键词:
AcuteAnti-Inflammatory AgentsAnti-inflammatoryBody SurfaceCD8B1 geneCellsCollaborationsCompanionsComplementComplexCytomegalovirus InfectionsDendritic CellsDevelopmentDoseFoundationsGenerationsGoalsHumanImmuneImmune responseImmune systemInfectionInflammationInflammatoryInflammatory ResponseInfluenzaInfluenza A Virus, H5N1 SubtypeInjuryInterleukin-10InterventionLaboratoriesLiverLungLung InflammationMediatingMediator of activation proteinModelingMononuclearMurid herpesvirus 1MusNatural Killer CellsOrganOutcomePhasePhenotypePlayPneumoniaProcessProductionPropertyProteinsRecoveryRegulationReporterResearch DesignRespiratory SystemRespiratory Tract InfectionsRespiratory tract structureRoleSARS coronavirusSeveritiesSignal TransductionSiteSourceStructure of parenchyma of lungSurfaceT-LymphocyteTechniquesTestingTissuesType A InfluenzaViralVirusVirus DiseasesVirus Replicationcell motilitycell typechemokinecostcytokinedesigninfluenzavirusinsightlung injurymacrophagemonocytereceptorresearch studyrespiratoryrespiratory infection virusresponse
中文摘要
肺部炎症和损伤是病毒感染的常见结果(在某些情况下甚至是致命的)
对呼吸道的影响。呼吸道病毒感染触发宿主先天和
适应性免疫系统。宿主响应对于病毒清除和恢复至关重要,但也是一种
伴随病毒清除而导致肺损伤的重要原因。最近的相关例子
人类感染SARS冠状病毒时是否观察到免疫介导的肺部炎症/损伤
以及H5N1禽流感病毒。项目1的长期目标是定义和描述
天然免疫系统中树突状细胞、单核/巨噬细胞、NK细胞之间的相互作用
和获得性免疫效应T淋巴细胞(Tej)在病毒清除和控制过程中的作用
呼吸道实验性病毒感染期间的炎症/损伤。
这一应用的基础是我们最近在A型小鼠模型中出人意料的发现
流感感染,抗病毒效应T细胞(包括CD4+Te和更突出的CDS+Te)渗透
在Te过程中,感染的肺产生高水平的抗炎/调节细胞因子IL-10
对感染和病毒清除的反应。此外,我们还发现阻断Te来源的IL-1的作用。
10感染期间会导致肺部炎症增加和致命性损伤。我们的证据进一步
提示这种Te来源的IL-10在控制肺部炎症/损伤水平中起核心作用
由单个核细胞渗入受感染的肺以应对病毒感染和促炎反应而产生
病毒免疫(Te)释放的介体。我们想要分析的是表达和调控
IL-10和特异性Te来源的IL-10在感染肺中的表达及该细胞因子对对照的影响
病毒清除和肺部炎症/损伤。项目1的目标是:1.评估细胞
IL-10的来源及其在流感病毒感染中的作用;2.分析IL-10的产生调节
确定病毒感染对Te来源的IL-2产生的影响。
10.拟议的研究旨在补充项目2、3和4中正在进行的相关研究。
英文摘要
Pulmonary inflammation and injury is a frequent (and, in some instances, lethal) outcome of virus infections
of the respiratory tract. Respiratory virus infection triggers a coordinated response from the host innate and
adaptive immune systems. The host response is essential for virus clearance and recovery, but is also a
significant cause of pulmonary injury that can accompany virus elimination. Relevant recent examples of this
are the immune-mediated lung inflammation/injury observed in human infections with the SARS coronavirus
and the H5N1 avian influenza viruses. The long-term goal of Project 1 is to define and characterize the
interactions between cells of the innate immune system i.e. dendritic cells, monocyte/ macrophage, NK cells
and adaptive immune effector T lymphocytes (Tej in the process of virus clearance and in the control of
inflammation/injury during experimental virus infection of the respiratory tract.
The foundation for this application is our recent and unexpected findings in the murine model of type A
influenza infection that anti-viral effector T-cells (both CD4 +Te and more prominently CDS +Te) infiltrating
the infected lungs produce high levels of the anti-inflammatory/regulatory cytokines IL-10 during the Te
response to infection and virus elimination. Furthermore, we found that blocking the effect of Te-derived IL-
10 during infection results in increased pulmonary inflammation and lethal injury. Our evidence further
suggests that this Te-derived IL-10 plays a central role in controlling the level of lung inflammation/injury
produced by mononuclear cells infiltrating the infected lungs in response to virus infection and the proinflammatory
mediators released by virus- immune (Te). We wish to analyze the expression and regulation
of IL-10 and specifically Te-derived IL-10 in the infected lungs and the impact of this cytokine on the control
of virus clearance and lung inflammation/injury. The aims of Project 1 are: 1. To evaluate the cellular
sources and effects of IL-10 on influenza virus infection; 2. To analyze the regulation of IL-10 production by
Te during influenza infection; 3. To determine the impact of viral infection on the production of Te-derived IL-
10. The proposed studies are designed to complement ongoing related studies in Projects 2, 3 and 4.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Leukotriene modifying agents in the prevention of excess morbidity and mortality from influenza
-
批准号:9756319
-
项目类别:
-
资助金额:$70.26万
-
财政年份:2018
-
负责人:Thomas J Braciale
-
依托单位:
Leukotriene modifying agents in the prevention of excess morbidity and mortality from influenza
-
批准号:9978695
-
项目类别:
-
资助金额:$63.66万
-
财政年份:2018
-
负责人:Thomas J Braciale
-
依托单位:
Adipokines in Pulmonary Viral Infection
-
批准号:8974711
-
项目类别:
-
资助金额:$23.7万
-
财政年份:2015
-
负责人:Thomas J Braciale
-
依托单位:
Adipokines in Pulmonary Viral Infection
-
批准号:9089941
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2015
-
负责人:Thomas J Braciale
-
依托单位:
Immune Regulation of Virus Clearance and Tissue Injury at Sites of Infection
-
批准号:8474683
-
项目类别:
-
资助金额:$147.87万
-
财政年份:2009
-
负责人:Thomas J Braciale
-
依托单位:
Immune Regulation of Virus Clearance and Tissue Injury at Sites of Infection
-
批准号:7872856
-
项目类别:
-
资助金额:$157.37万
-
财政年份:2009
-
负责人:Thomas J Braciale
-
依托单位:
Immune Regulation of Virus Clearance and Tissue Injury at Sites of Infection
-
批准号:7679778
-
项目类别:
-
资助金额:$155.72万
-
财政年份:2009
-
负责人:Thomas J Braciale
-
依托单位:
Immune Regulation of Virus Clearance and Tissue Injury at Sites of Infection
-
批准号:8282813
-
项目类别:
-
资助金额:$157.31万
-
财政年份:2009
-
负责人:Thomas J Braciale
-
依托单位:
Administration
-
批准号:7746106
-
项目类别:
-
资助金额:$12.65万
-
财政年份:2009
-
负责人:Thomas J Braciale
-
依托单位:
Immune Regulation of Virus Clearance and Tissue Injury at Sites of Infection
-
批准号:8096720
-
项目类别:
-
资助金额:$157.24万
-
财政年份:2009
-
负责人:Thomas J Braciale
-
依托单位:
CD8+ T cell trafficking to the normal lung
-
批准号:6725653
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2004
-
负责人:Thomas J Braciale
-
依托单位:
CD8+ T cell trafficking to the normal lung
-
批准号:7204196
-
项目类别:
-
资助金额:$36.15万
-
财政年份:2004
-
负责人:Thomas J Braciale
-
依托单位:
CD8+ T cell trafficking to the normal lung
-
批准号:7026951
-
项目类别:
-
资助金额:$37.23万
-
财政年份:2004
-
负责人:Thomas J Braciale
-
依托单位:
CD8+ T cell trafficking to the normal lung
-
批准号:6875017
-
项目类别:
-
资助金额:$38.05万
-
财政年份:2004
-
负责人:Thomas J Braciale
-
依托单位:
RESPIRATORY SYNCYTIAL VIRUS AND ATOPIC PULMONARY RESPONSE
-
批准号:6345923
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2000
-
负责人:Thomas J Braciale
-
依托单位:
RESPIRATORY SYNCYTIAL VIRUS AND ATOPIC PULMONARY RESPONSE
-
批准号:6201176
-
项目类别:
-
资助金额:$19.31万
-
财政年份:1999
-
负责人:Thomas J Braciale
-
依托单位:
RESPIRATORY SYNCYTIAL VIRUS AND ATOPIC PULMONARY RESPONSE
-
批准号:6099672
-
项目类别:
-
资助金额:$19.31万
-
财政年份:1998
-
负责人:Thomas J Braciale
-
依托单位:
RESPIRATORY SYNCYTIAL VIRUS AND ATOPIC PULMONARY RESPONSE
-
批准号:6235144
-
项目类别:
-
资助金额:$18.75万
-
财政年份:1997
-
负责人:Thomas J Braciale
-
依托单位:
INTERDISCIPLINARY TRAINING PROGRAM IN IMMUNOLOGY
-
批准号:6372824
-
项目类别:
-
资助金额:$31.1万
-
财政年份:1995
-
负责人:Thomas J Braciale
-
依托单位:
INTERDISCIPLINARY TRAINING PROGRAM IN IMMUNOLOGY
-
批准号:2875371
-
项目类别:
-
资助金额:$28.67万
-
财政年份:1995
-
负责人:Thomas J Braciale
-
依托单位:
海外基金